Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM495169 (3-[(2,4-Dimethylthiazol-5-yl)methyl]-N-(1-methylcy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10995073 (2021) BindingDB Entry DOI: 10.7270/Q28K7D68 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421539 (3-[(2,4-Dimethylthiazol-5-yl)methyl]-N-(1-methylcy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421556 (3-[(4-Fluorophenyl)methyl]-N-(1-methylcyclopropyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421556 (3-[(4-Fluorophenyl)methyl]-N-(1-methylcyclopropyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10995073 (2021) BindingDB Entry DOI: 10.7270/Q28K7D68 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421584 (3-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]-6-flu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10995073 (2021) BindingDB Entry DOI: 10.7270/Q28K7D68 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421584 (3-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]-6-flu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421497 (US10508086, Example 87 | US10995073, Example 87) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421497 (US10508086, Example 87 | US10995073, Example 87) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10995073 (2021) BindingDB Entry DOI: 10.7270/Q28K7D68 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371026 (US10239843, Example 133) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371049 (US10239843, Example 156) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371051 (US10239843, Example 158) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371054 (US10239843, Example 161) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371055 (US10239843, Example 162) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371056 (US10239843, Example 163) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371058 (US10239843, Example 165) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421482 (US10508086, Example 73 | US10995073, Example 73) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421488 (US10508086, Example 79 | US10995073, Example 79) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421492 (US10508086, Example 82 | US10995073, Example 82) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421493 (US10508086, Example 83 | US10995073, Example 83) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421498 (US10508086, Example 88 | US10995073, Example 88) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM205480 (PDD00017238 (5) | US10508086, Example 90 | US10995...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421482 (US10508086, Example 73 | US10995073, Example 73) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10995073 (2021) BindingDB Entry DOI: 10.7270/Q28K7D68 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421488 (US10508086, Example 79 | US10995073, Example 79) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10995073 (2021) BindingDB Entry DOI: 10.7270/Q28K7D68 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421492 (US10508086, Example 82 | US10995073, Example 82) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10995073 (2021) BindingDB Entry DOI: 10.7270/Q28K7D68 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421493 (US10508086, Example 83 | US10995073, Example 83) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10995073 (2021) BindingDB Entry DOI: 10.7270/Q28K7D68 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421498 (US10508086, Example 88 | US10995073, Example 88) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10995073 (2021) BindingDB Entry DOI: 10.7270/Q28K7D68 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM205480 (PDD00017238 (5) | US10508086, Example 90 | US10995...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10995073 (2021) BindingDB Entry DOI: 10.7270/Q28K7D68 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM370915 (1-(Cyclopropylmethyl)-4-methyl-N-(1-methylcyclopro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421626 (3-[5-(Difluoromethyl)-1,3,4-thiadiazol-2-yl]-6-flu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10995073 (2021) BindingDB Entry DOI: 10.7270/Q28K7D68 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM370973 (US10239843, Example 80) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM370991 (US10239843, Example 98) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371186 (US10239843, Example 293) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371191 (US10239843, Example 298) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371201 (US10239843, Example 308) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371204 (4-(Cyclopropanecarbonyl)-N-(1-methylcyclopropyl)-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371066 (US10239843, Example 173) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371355 (1-[(2,4-Dimethylthiazol-5-yl)methyl]-N-[1-(fluorom...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371376 (1-Chloro-N-(1-methylcyclopropyl)isoquinoline-7-sul...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371463 (N-[1-(Fluoromethyl)cyclopropyl]-3-[(1-methylpyrazo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371469 (N-[1-(Fluoromethyl)cyclopropyl]-1-(isothiazol-5-yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371470 (N-[1-(Fluoromethyl)cyclopropyl]-1-[(5-methylisoxaz...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371493 (1-Ethyl-N-[1-(fluoromethyl)cyclopropyl]-3-[(5-meth...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371504 (1-Ethyl-N-(1-methylcyclopropyl)-3-[(5-methyl-1,3,4...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371506 (1-[(2,4-Dimethylthiazol-5-yl)methyl]-N-[1-(fluorom...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371507 (1-Butyl-N-[1-(fluoromethyl)cyclopropyl]-3-[(1-meth...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371073 (US10239843, Example 180) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371514 (N-[1-(Fluoromethyl)cyclopropyl]-1-methyl-3-[(3-met...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371518 (1-(2-Fluoroethyl)-N-[1-(fluoromethyl)cyclopropyl]-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371519 (N-[1-(Fluoromethyl)cyclopropyl]-1-[(1-methylpyrazo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM371520 (N-[1-(Fluoromethyl)cyclopropyl]-1-[(5-methyl-1,2,4...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Istituto Superiore di Sanita | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | J Med Chem 51: 1058-62 (2008) BindingDB Entry DOI: 10.7270/Q21R6SSM | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 73 total ) | Next | Last >> |